BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 19396741)

  • 1. Virtual screening - what does it give us?
    Köppen H
    Curr Opin Drug Discov Devel; 2009 May; 12(3):397-407. PubMed ID: 19396741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual screening of compound libraries.
    Cerqueira NM; Sousa SF; Fernandes PA; Ramos MJ
    Methods Mol Biol; 2009; 572():57-70. PubMed ID: 20694685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and virtual screening of target libraries.
    Rognan D
    J Physiol Paris; 2006; 99(2-3):232-44. PubMed ID: 16459061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective.
    Rester U
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):559-68. PubMed ID: 18600572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring.
    Radestock S; Weil T; Renner S
    J Chem Inf Model; 2008 May; 48(5):1104-17. PubMed ID: 18442221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of computational methods in the identification of bioactive compounds.
    Glick M; Jacoby E
    Curr Opin Chem Biol; 2011 Aug; 15(4):540-6. PubMed ID: 21411361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of QSAR and shape pharmacophore modeling approaches for targeted chemical library design.
    Ebalunode JO; Zheng W; Tropsha A
    Methods Mol Biol; 2011; 685():111-33. PubMed ID: 20981521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel technologies for virtual screening.
    Lengauer T; Lemmen C; Rarey M; Zimmermann M
    Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A linear discrimination analysis based virtual screening of trichomonacidal lead-like compounds: outcomes of in silico studies supported by experimental results.
    Meneses-Marcel A; Marrero-Ponce Y; Machado-Tugores Y; Montero-Torres A; Pereira DM; Escario JA; Nogal-Ruiz JJ; Ochoa C; Arán VJ; Martínez-Fernández AR; García Sánchez RN
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3838-43. PubMed ID: 16005626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of virtual screening as a tool for chemical genetic applications.
    Campagna-Slater V; Schapira M
    J Chem Inf Model; 2009 Sep; 49(9):2082-91. PubMed ID: 19702241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond the virtual screening paradigm: structure-based searching for new lead compounds.
    Schlosser J; Rarey M
    J Chem Inf Model; 2009 Apr; 49(4):800-9. PubMed ID: 19354328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A discussion of measures of enrichment in virtual screening: comparing the information content of descriptors with increasing levels of sophistication.
    Bender A; Glen RC
    J Chem Inf Model; 2005; 45(5):1369-75. PubMed ID: 16180913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y; Schneider G
    Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection criteria for drug-like compounds.
    Muegge I
    Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of G-protein coupled receptor models in lead optimization.
    Tautermann CS
    Future Med Chem; 2011 Apr; 3(6):709-21. PubMed ID: 21554077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in computer-aided drug design.
    Song CM; Lim SJ; Tong JC
    Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarity search profiles as a diagnostic tool for the analysis of virtual screening calculations.
    Xue L; Godden JW; Stahura FL; Bajorath J
    J Chem Inf Comput Sci; 2004; 44(4):1275-81. PubMed ID: 15272835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.